Clinical Trials Directory

Trials / Sponsors / SPP Pharmaclon Ltd.

SPP Pharmaclon Ltd.

Industry · 9 registered clinical trials.

StatusTrialPhaseStarted
UnknownA Multicenter Clinical Trial of Ingaron in Pulmonary Tuberculosis
Respiratory Tuberculosis
—2022-06-01
UnknownStudy on the Use of Interferon Gamma (Ingaron) Injections in Patients With Drug-resistant Pulmonary Tuberculos
Pulmonary Tuberculosis
—2022-04-15
CompletedStudy of the Use of Nasal IFN-γ in Patients for the Prevention of Acute Respiratory Viral Infections, Icluding
COVID-19 Respiratory Infection, Acute Respiratory Disease
N/A2020-12-21
CompletedStudy of the Use of the Ingaron in Volunteers for the Prevention of COVID-19
COVID-19 Respiratory Infection
—2020-04-23
CompletedStudy of the Use of the Drug Ingaron in Patients With COVID-19
COVID-19 Respiratory Infection, Viral Pneumonia
—2020-04-21
CompletedStudy of Ingaron's Effect on Efficacy and Resistance to Antibiotics in Community-acquired Pneumonia
Community-acquired Pneumonia
N/A2017-05-12
CompletedStudy of the Efficacy and Safety of the Drug Ingaron (Interferon-gamma) in the Treatment of Anogenital Warts
Human Papillomavirus Infection, Anogenital Warts
Phase 32009-05-18
CompletedEfficiency and Safety of the Drug Ingaron (Interferon-gamma Human Recombinant) in the Treatment of Chronic Pro
Chronic Prostatitis
Phase 32009-01-29
CompletedStudy of Interferon-Gamma in the Complex Treatment of Patients Infected With HIV and Tuberculosis
HIV Coinfection, Aids/Hiv Problem, Tuberculosis, Pulmonary
Phase 1 / Phase 22006-01-19